ARKIVOC INSTRUCTIONS TO AUTHORS
CONTENTS
1. Editorial Policy of Arkivoc
1.1 Manuscript requirements
1.2 Evaluation of manuscripts
1.3 Date of receipt
2. Preparation of Manuscript, Supplementary Materials, and
Graphical Abstract
2.1 Manuscript text
2.1.1 The language of publication
2.1.2 Word processor
2.1.3 Macros and bookmarks
2.1.4 Text file format
2.2 Organization of the manuscript
2.2.1 Manuscripts headings for original research papers
2.2.2 Manuscripts headings for reviews and accounts
2.2.3 Title
2.2.4 Author's name(s)
2.2.5 Author's address(es), corresponding author's e-mail
address
2.2.6 Dedication
2.2.7 Abstract
2.2.8 Keywords
2.2.9 Headings font size and style, alignment
2.2.10 Table of Contents - Reviews and Accounts only
2.2.11 Introduction
2.2.12 Results and Discussion
2.2.13 Conclusions
2.2.14 Experimental Section
2.2.15 Acknowledgements
2.2.16 References
2.2.17 Authors' Biographies - required for Accounts and
Reviews only
2.3 Tables
2.4 Graphics
2.4.1 Schemes, equations, and structure blocks
2.4.2 Figures
2.5 Supplementary materials
2.6 Graphical abstract
3. Submission of Manuscript
3.1 Submission procedure
3.2 Refereeing procedure and editing of the manuscript
3.3 Revision of manuscript
3.4 Copyright agreement
4. Model Experimental Section
AUTHOR ALERT
Authors' attention is drawn to the new style for listing references cited in manuscripts submitted. MPublishing, which provides publishing services to Arkivoc, is now a member of CrossRef, and consequently, DOIs (digital object identifiers) are being assigned to all Arkivoc papers that have been published. This should help to ensure maximum visibility of your work published in Arkivoc since this linking system is used by all major journals. Participation in the system requires that all references cited should include a DOI when one is available. We ask for your cooperation in using the new style to facilitate our work in assigning DOIs to references. It is not necessary for authors to provide DOIs. Please refer to the Arkivoc Instructions to Authors (Section 2.2.16) for full details of the format for reference citing and listing. Manuscripts that do not use the correct format will be returned to authors for revision prior to review.
1. Editorial Policy of Arkivoc
1.1 Manuscript requirements
It is the responsibility of the senior author to ensure that all named authors have made a significant contribution to the work described in the manuscript and that all authors have seen and approved the manuscript prior to submission.
The manuscript of a full paper must be based on original research by the authors and the work must not have been published previously either in print or electronic format (exception: dissertations).
Manuscripts should be submitted to Arkivoc on an exclusive basis and must not be under simultaneous consideration by another journal.
If reference is made to an unpublished paper (“submitted” or “in press”), a copy of that manuscript should be provided by the author with the submission.
Medicinal Chemistry. Arkivoc is an organic chemistry journal and does not publish papers that are primarily concerned with medicinal chemistry. The journal does publish manuscripts with some medicinal chemistry content if the synthetic chemistry is novel and of general interest to organic chemists. Biological test results, if included, should form only a minor part of the manuscript, and biological results that are particularly significant or promising are more suitable for a medicinal chemistry journal. The final decision to publish such papers resides with the editors.
1.2 Evaluation of manuscripts
Contributions will be evaluated initially by the Primary Review Committee. Manuscripts that fulfil the essential scientific and editorial requirements for publication in Arkivoc will be reviewed by two or more members of the Editorial Board of Referees who advise the Scientific Editors on the suitability for publication. Authors are requested to submit three suggestions for referees.
Manuscripts that are unsound or have inadequate characterization of new compounds will not be accepted.
1.3 Date of receipt
The "date of receipt" recorded in the published article will be the date when a complete submission that satisfies all the requirements of the Technical Editor is received in the editorial office.
2. Preparation of Manuscript, Supplementary Materials, and Graphical Abstract (Please note that "Communications" are not published in Arkivoc)
2.1 Manuscript text
Because Arkivoc is published online and in a printed version, it is essential that the files for both versions are compatible. In order to achieve this, authors are required to use the appropriate template for the preparation of a paper, account, orreview. If, for technical reasons, this is not possible, the following format must be strictly adhered to. Failure to comply will result in the paper being returned for amendments before further consideration. Authors should refer to the sample paper or review for precise details of layout and format. For guidance on grammar, and chemical-usage in the preparation of manuscripts authors are recommended to consult The ACS Style Guide, Coghill, A. M.; Garson, L. R. Eds.; 3rd Edn.; Oxford University Press, 2006 (ISBN-13; 978-0-8412-3999-9). In a case of conflict between these sources, follow usage in a recent Arkivoc paper on the website.
2.1.1 The language of publication is English.
2.1.2 Word processor
Manuscripts must be prepared using MS Word as a doc file.
Manuscripts in pdf format CANNOT be accepted.
2.1.3 Macros and bookmarks: manuscripts containing macros and bookmarks CANNOT be accepted.
2.1.4 Text file format
Page setup: page size: US Letter (8.5 by 11 in, 22 by 28 cm.); margins on all sides are 1 in (2.54 cm).
Line spacing: setting "at least 16 pt."
Font: Times New Roman.
Text: 12 pt, normal, justified (left and right).
Symbols: Special characters (Greek letters, accents, mathematical symbols) must belong to the Times New Roman character set, i.e. must belong to the "normal text" Font in the Symbol selection window.
2.2 Organization of the manuscripts
2.2.1 Manuscripts for original research papers should have the following headings: Title
Author's name(s)
Author's address(es), affiliation(s), corresponding author's address
Dedication (optional)
Abstract
Keywords
Introduction
Results and Discussion
Experimental Section
Supplementary Material Available (optional)
Acknowledgements (optional)
References
2.2.2 Manuscripts comprising reviews and accounts should have the following headings:
Title
Author's name(s)
Author's address(es), affiliation(s), corresponding author's address
Dedication (optional)
Abstract
Keywords
Table of Contents(ToC)
Introduction
Main Headings of Contents
Acknowledgements (optional)
References
Authors' Biographies
2.2.3 Title
The title should clearly describe the purpose of the paper and should not include abbreviations (16 pt, bold, centered; followed by one empty line). Only the first letter of the title and of proper names in the title (e.g., Lewis acid) should be capitalized.
标题应该清晰地描述文章的目的，不应包括缩略语（16磅，加粗，居中，后面跟着一个空行）。仅在标题（例如，路易斯酸）专有名称的标题和首字母应该大写。
2.2.4 Author's name(s)
Typically, the following should be provided for each author:
Given name, middle initial and surname (12 pt, bold, centered; followed by one empty line).
The name of the corresponding author should be marked with an asterisk (*). If authors are from different institutions their surnames should be labeled after the name with a lower case superscript letter referring to the authors' addresses.
Example: Albert J. Jones,a Dalpat Patel,b and Arthur Other b*
The senior author must have the agreement of all authors for their names to appear on the paper.
通常情况下，以下应为每个作者：
给定的名字，中间名首字母和姓（12磅，加粗，居中，后面跟着一个空行）。
对应的作者的名称应标有星号（*）。如果作者是来自不同的机构，但他们的姓氏应该以小写字母上标指的是作者的地址，名称后加上标签。
例如：阿尔伯特J.琼斯，Dalpat帕特尔，b和亚瑟Otherb*
资深作家必须具有的所有作者对他们的名字的协议出现在纸上。
2.2.5 Author's address(es), corresponding author's e-mail address
The complete mailing address(es) of author(s) should include the name of the institutional affiliation, street or P.O. box number, city, postal code, and country (12 pt, italic, centered).
The address line should be followed by the e-mail address of the corresponding author (12 pt, italic, centered; with hyperlink; followed by one empty line).
的作者（S）的完整的邮寄地址（ES）应包括工作单位，街道的名称或PO箱号，城市，邮政编码和国家（12磅，斜体，居中）。
地址线应遵循的通讯作者（12磅，斜体，居中，与超链接，后面跟着一个空行）的电子邮件地址。
2.2.6 If a Dedication is desired, it should appear after a one line space below the e-mail address (12 pt, bold, centered).
2.2.7 Abstract
All manuscripts must be accompanied by a written abstract, which should state the purpose of the research, the principal results and major conclusions. The use of numbers in the abstract identifying formulas or tables is discouraged because the abstract text should be comprehensible when read alone. A typical abstract should contain no more than 100 words.
Abstract: Heading: 12 pt, bold, justified. Abstract text (on next line): 12 pt, normal, justified; followed by two empty lines.
所有稿件必须附有一份书面摘要，其中应说明研究的主要结果和主要结论的目的。使用在抽象的识别公式或表的数字是不鼓励，因为当独自阅读抽象的文字应该是可以理解的。一个典型的抽象应该包含不超过100字。
摘要：标题：12磅，加粗，合理的。摘要文本（下一行）：12磅，正常的，合理的;其次是两个空行。
2.2.8 Keywords: the Abstract should be followed four to six keywords.
Keywords subheading:12 pt, bold, colon, followed by keywords (first one capitalized and separated by commas): 12 pt, Times New Roman, left justified. There should be two spaces before the next heading.
关键词：摘要应遵循四到六个关键字。
关键词副标题：12磅，加粗，冒号，然后是关键字（第一资本化，并以逗号分隔）：12磅，宋体，左对齐。应该有两个空格的下一个标题之前。
2.2.9 Headings font size and style, alignment:
Major section headings (Introduction, Results and Discussion, Experimental Section, References, etc.): 14 pt, bold, left justified. There should be two spaces between sections and one space between each section heading and the text. The first paragraph of the text after major headings should not be indented.
Section subheadings: 12 pt, bold, left justified. Text begins on the following line and should not be indented.
Paragraphs should be indented (recommended 0.25 in or 0.64 cm) except the first paragraph after a section heading. In the Experimental Section paragraphs should not be indented.
主要章节标题（引言，结果与讨论，实验部分，参考文献等）：14磅，加粗，左
对齐。应该有节，每节标题和文本之间有一个空格之间的两个空格。文字的主要标题后的第一款不应该缩进。
第副标题：12磅，加粗，左对齐。文字开始下一行，不应该缩进。
段应缩进（建议在0.25或0.64公分），除了一节的标题后的第一款。在实验部分段落不应该被缩进。
2.2.10 Reviews and Accounts - Table of Contents (ToC)
A ToC should appear above the Introduction for Reviews and Accounts. Headings in Reviews and Accounts should follow the hierarchy and style as indicated below. The Introduction should be numbered 1.
1. Primary Heading (14pt bold)
1.1 Secondary heading (12pt bold)
1.1.1 Tertiary heading. (12pt bold, run on)
2. Primary Heading
通过TOC应该出现在引言的评价和账户上面。在评价和账户标题应遵循的层次结构和如下所示的样式。引言应被编号为1。
1，主标题（14pt标粗体）
1.1二级标题（宋体加粗）
1.1.1三级标题。（宋体加粗，运行）
2，主标题
2.2.11 Introduction
An introductory paragraph or statement should be given, placing the work in the appropriate context and clearly stating the purpose and objectives of the research.
2.2.11简介
一个介绍性段落或语句应该给，把工作在适当的范围内，并明确说明的目的和研究目的。
2.2.12 Results and Discussion
All significant results that need to be rationalized should be discussed in this section. Experimental details should be kept to a minimum and reiteration of information from Tables, Figures, and Schemes should be avoided.
2.2.12结果与讨论
需要合理化所有显著成绩应在本节进行讨论。实验细节应保持的信息的最小和重申从表中，图中，并应避免方案。
2.2.13 Conclusions
A brief Conclusions section is desirable, but not essential.
2.2.13结论
一个简短的结论部分是可取的，但不是必需的。
2.2.14 Experimental Section
General. This section should contain a description of instruments (make and model), and any special procedures used. The sources of all commercially available chemicals along with the source of all combustion analytical data, or work done outside the authors? institution should be given.
通用。这部分应包含工具（品牌和型号），以及任何特别程序使用的说明。连同所有的燃烧分析数据，或作者的机构之外进行工作的源头市场上所有的化学品的来源应该放在首位。
Synthetic procedures in the experimental section should be accompanied by a listing of the most important product characterization data. Each paragraph describing a synthetic experiment should give the product?s systematic (IUPAC) name and the structure number assigned to the compound in the discussion section. Use of standard abbreviations or unambiguous molecular formulas for reagents and solvents, and of structure numbers rather than chemical names to identify starting materials and intermediates, is encouraged. Reactant and reagent quantities should be given in both weight and molar units. Yields should represent weighed amounts of isolated and purified products, and should be reported as percentages. When flash chromatography is used for product purification, both the support and eluting solvent should be identified.
在实验部分合成过程应伴随着最重要的产品特性数据的列表。每个段落描述一个合成实验应该给产品的系统（IUPAC）的名称和分配给在讨论部分该化合物的结构数量。使用标准缩写或明确的分子通式为试剂和溶剂，以及结构的数字而不是化学名称来标识的起始原料和中间体，是鼓励。反应物和试剂的数量应在重量和摩尔单位给出。收益率应该代表的分离和纯化产品称重值，并应报告为百分比。当快速色谱法用于纯化产物，二者的支持和洗脱溶剂应加以鉴别。
Abbreviations, acronyms, symbols, and physical constants. Common abbreviations, acronyms, and symbols may be used, but less common ones should be defined the first time they are used (see the ACS Style Guide). Usage within a paper should be consistent,
e.g., either Ph or C
6H
5
for phenyl, not both. Note: Ph should not be used for C
6
H
4
. The
symbols used for physical constants should be in italics (e.g. d, J, k, c, m/z), but the units for physical constants should not be italicized. Equal signs should be avoided in citing data, e.g. J 5.1 Hz not J = 5.1 Hz.
缩写，首字母缩写，符号和物理常数。常见的缩写，缩略语和符号可以被使用，但较不常见的人应该被定义在第一次被使用（见ACS的设计指南）。纸中的使用应
该是一致的，例如，pH或C6H5的苯基，而不是两个。注：pH值不应该被用来为C6H4。用于物理常数的符号应为斜体（如D，J，K，C，M / Z），但单位物理常
数不应该出现斜体。等号应避免在引用数据，如?5.1赫兹不是J =5.1赫兹。
QSAR studies. Arkivoc considers only those QSAR papers that meet the following criteria: (i) the work must involve statistical treatment of results obtained from the authors? laboratory (they must not be culled from the published literature) and (ii) the paper should include a practical (experimental) element, as appropriate to an organic chemistry journal. 定量构效关系研究。 Arkivoc认为只有符合以下条件的定量构效关系的论文：（i）本工作必须涉及从作者的实验室获得的结果进行统计处理（它们不能从公开发表的文献剔除）及（ii）本文件应包括一个实用的（实验）的元素，如适用于有机化学期刊。
Microwave reactors. Work conducted in microwave reactors must indicate whether sealed or open reaction vessels were used and must document the manufacturer and model of the reactor, the method of monitoring the reaction mixture temperature (external surface sensor or internal probe), and the temperature reached or maintained in each experiment. Please note that Arkivoc does not publish reports of studies conducted with domestic (kitchen) microwave ovens.
微波反应器。在微波反应器中进行工作，必须表明是否封闭或开放的反应容器中使用，必须记录反应器的制造商和型号，监测反应混合物的温度（外部传感器表面或内部探头）的方法，以及温度达到或维持每个实验。请注意，Arkivoc不发布与国
内（厨房）微波炉进行了研究报告。
Compound characterization data. Arkivoc upholds high standards for compound characterization to ensure that compounds being added to the chemical literature have been correctly identified and could be synthesized in known yield and purity by the reported preparation, isolation, and purification methods. For all new compounds, evidence adequate to establish both identity and degree of purity (homogeneity) must be provided. Purity documentation must be provided for known compounds whose preparation by a new or improved method is reported. If, in the opinion of the Scientific Editor, new compounds have not been satisfactorily characterized, the paper will not be accepted.
化合物的特征数据。 Arkivoc坚持高标准化合物的表征，以确保化合物被添加到化学文献中已被正确地识别并能以已知的产率和纯度的报道制备，分离和纯化的方法合成。对所有新化合物，证据充分建立纯度（同质性）的身份和度必须提供。纯度文件必须向已知化合物，其制备通过一种新的或改进的方法的报道。如果在科学的编辑认为，新化合物并没有得到很好的特点，本文将不被接受。
For known compounds synthesized by published methods, the method of preparation, the literature data used to confirm the identity of the material, and the technique(s) used to determine purity should be reported. For known compounds prepared by new or modified synthetic reactions, the types of physical and spectroscopic data that were found to match cited literature data should be identified, and purity documentation (see below) should be provided. Listings of IR and NMR absorptions and MS peaks for known compounds should be included only if they do not duplicate published data.
Evidence for the identity of new compounds should include both1H and 13C NMR
data and either HRMS or elemental analysis data. A criterion of purity (see below) must also be provided with HRMS data.
用于通过已公开的方法合成的已知化合物，其制备方法，应报告用于确认该材料的同一性和技术（次）用于确定纯度的文献数据。对于准备通过新的或修改合成反应的已知化合物，被发现matchcited文献数据的物理和光谱数据类型应确定和纯度文件（见下文）应提供。的IR和NMR吸收和质谱峰为已知化合物，目录应包含唯一的，如果他们不重复发表的数据。
对于新化合物的身份凭证应包括H和13 C NMR数据与任一HRMS或元素分析数据。纯度（见下文）的标准，还必须提供与人力资源管理系统的数据。
Proton and carbon NMR resonance signals should be listed for each new compound; the solvent and instrument frequency should be identified. Carbon NMR peak shifts
should be rounded off to the nearest 0.1 ppm. Hydrogen multiplicity (C, CH, CH
2, CH
3
)
information (APT) obtained from carbon DEPT or 2D spectra may be included with the carbon peak shifts, if available, but is not essential information. The J values for all signals described as …d?, …t?, etc., must be given. For an example of the format for reporting NMR data, see the model Experimental Section at the end of the Instructions to Authors.
For new compounds, either HRMS (resolution 0.001 m/z unit or better) or combustion elemental analysis data should be reported to support the molecular formula assignment. The reported data should include the molecular formulae on which the theoretical (Calcd) values are based.
HRMS molecular formulae and Calcd values should include any added atoms (usually H or Na). The ionization method should be reported and a criterion of purity provided. A
Found value within 0.003 m/z unit of the Calcd value of a parent-derived ion (for molecular weights less than 500), together with other available data (including knowledge of the elements present in reactants and reagents) is usually adequate for uniquely determining a molecular formula.
质子和碳NMR共振信号，应列出每个新化合物;溶剂和仪器的频率应加以鉴别。碳核磁共振峰位移应四舍五入到最接近的0.1 ppm的。从碳DEPT或2D谱得到氢复
数（C，CH，CH2，CH3）信息（APT）可以包含在碳峰的变化，如果有的话，但
不是必需的信息。 J值用于描述为'D'，'t'等等的所有信号，应予重视。对于报告NMR数据格式的示例，请参阅在投稿须知月底的模型实验部分。
新的化合物，无论是人力资源管理系统（分辨率0.001 M / Z单元或更好）或燃烧
元素分析数据，应当报以支持分子式分配。该报告的数据应包括在其上的理论（计算值）值所依据的分子式。
Elemental analysis. Found values for carbon, hydrogen, and nitrogen (if present) should be within 0.4% of the Calcd values for the proposed formula. The inclusion of fractional molecules of solvent or water in the molecular formula to improve the fit of the data usually reflects incomplete purification of the sample. If the reported formula includes such a molecule, independent evidence for its presence (such as NMR peaks with appropriate chemical shifts) should be presented. The format for reporting CHN analyses can be found in the model Experimental Section at the end of the Instructions to Authors.
元素分析。对碳，氢和氮中找到的值（如果存在的话）应在该计算值的值的0.4％
为建议的公式。在其分子结构式来改善数据的拟合列入溶剂或水分子的分数，通常反映了样品的不完全纯化。如果报告的公式中包含了这种分子，独立的证据，它的存在（如核磁共振峰与相应的化学位移）应提交。报告CHN分析的格式可以在模
型实验部分在投稿须知的末尾找到。
Specific rotation. Specific optical rotations should be reported for isolated natural products, enantiopure compounds, and enantioenriched isomer mixtures when sufficient sample is available. Specific rotations based on the equation [α] = (100.α)/(l.c) should be reported as unitless numbers as in the following example: [α]D20 -25 (c 1.9, CHCl
), where
3
the concentration c is in g/l00 mL and the path length l is in decimeters. The units of the specific rotation, (deg.mL)/(g.dm), are implicit and should not be included with the reported value.
比旋度。具体的旋光度应为隔离天然产物，对映体纯化合物，当足够的样本可enantioenriched异构体混合物进行报告。根据公式[α]=（100.α）/（LC）比旋光度
应报告为无单位的数字，如下面的例子：[α] D20-25（C1.9，氯仿），其中浓度c
为g/l00 mL和路径长度l是分米。比旋光度（deg.mL）/（g.dm）的单位，是隐式的，不应该被包含在报告的值。
Melting point. A melting point range should be reported for every crystalline solid product, together with the solvent from which it was recrystallised, and a description of
the material e.g. "yellow needles, mp 123-124 °C (from EtOH)". For non-crystalline materials, there should also be a description, e.g. "brown oil; colorless gum". Similarly
for liquids, e.g. "colorless oil, bp 123 °C (120 mmHg)".
熔点。甲熔点范围应为每晶状固体产物进行报告，以从中重结晶的溶剂，将材料例如的描述一起“黄色针状结晶，熔点123-124℃（从乙醇）。”对于非结晶性材料，也应该有描述，例如“棕色油;无色胶状物”。同样，对于液体，例如“无色油状物，沸点123℃（120毫米汞柱）”。
IR and MS. Only those IR absorptions diagnostic for major functional groups, and only
those MS peaks used for structure assignment, should be included in the experimental section. Complete peak listings or copies of the spectra may be included in the supporting information. IR bands, when reported, should be indicated using an approximate scale of relative intensities (vs, s, m, w = very strong, strong, medium, weak). Significant MS peaks should be reported with their % intensity relative to the base peak of the spectrum. IR和MS。只有那些红外吸收峰诊断为主要的官能团，并且只用于结构分配的MS 峰，应包括在实验部分中。完整的峰列表或光谱的副本可以被包括在该辅助信息。红外波段，报道的时候，应该用相对强度的近似规模的指示（VS，S，M，W =非
常强，强，中，弱）。显著质谱峰应报告与其％相对于光谱中的基峰的强度。Purity. If a Scientific Editor feels it necessary to ask for evidence for compound purity, that evidence should include one or more of the following:
1. A standard 1D proton NMR spectrum or proton-decoupled 13C NMR spectrum showing, at most, trace peaks not attributable to the assigned structure.
2. Combustion elemental analytical values for carbon and hydrogen (and nitrogen, if present) agreeing with calculated values within 0.4%.
3. Quantitative gas chromatographic analytical data for distilled or vacuum-transferred samples, or quantitative HPLC analytical data for materials isolated by column chromatography or separation from a solid support.
4. For known solid compounds, a narrow melting point range that is in close agreement with a cited literature value.
纯度。如果一个科学的编辑认为有必要要求证据化合物的纯度，该证据应当includeone或多个以下：
1，一个标准的一维质子核磁共振光谱或质子去偶13C NMR谱显示，顶多跟踪不
可归责于给定的结构峰。
2，为碳和氢气（和氮气，如果存在的话）燃烧元素分析值同意与内0.4％计算值。3，定量气相色谱分析数据为蒸馏或真空转移样品，或用于分离材料通过柱色谱法或从固体支持物上分离的HPLC定量分析数据。
4，对于已知的固体化合物，狭窄的熔点范围，是与被引文献值接近一致。Spectra. Reproductions of spectra will be published in the results and discussion
section only when concise numerical summaries are inadequate for the discussion. Papers dealing primarily with interpretation of spectra, and those in which band shape or fine structure needs to be illustrated, may qualify for this exception. When presentation of spectra is essential, only the pertinent sections, should be included, either in the text or in supplementary information.
光谱。谱的复制品将刊登在结果和讨论部分，只有当简洁的数值总结不足的讨论。论文主要处理解释光谱，以及那些在带形或细结构需要加以说明，可能有资格获得此异常。当演示光谱是必不可少的，只有相关的部分，应列入，无论是在文字或补充资料。
Crystallographic data. Only data and graphics vital to the discussion should be included in the manuscript. If the data are used solely for confirming compound identity or stereochemistry, a statement in the results and discussion or experimental section that the assignment is supported by an X-ray crystallographic structure determination is usually sufficient, though a ball-and-stick drawing or thermal ellipsoid plot can be included if desired. Regardless of the level of detail of the discussion of the structure, a Crystallographic Information File (CIF) containing complete details of data collection, crystal and unit-cell parameters, structure solution and refinement, and tables of atomic
coordinates and thermal parameters, bond lengths, bond angles, and torsion angles should be furnished as supporting information. Reflection intensity data (structure factor tables) should not be included. If more than one crystal structure is being reported, the CIF for each structure should be furnished as a separate file. CIFs should be saved in text-only (plain ASCII) format and should be assigned file names that identify the structure number used in the manuscript and that include a ".cif" (not ".txt") extension. Before being submitted, CIFs should be checked and corrected using the free checkCIF data-validation utility at https://www.doczj.com/doc/b210113416.html,/services/cif/checkcif.html All structures for which an X-ray determination is included must also be submitted to the Cambridge Crystallographic Data Base and the unique number assigned to the compound in the data base, must be quoted in the experimental description of the compound.
晶体学数据。唯一的数据和图形的讨论非常重要，应包括在手稿。如果数据只用于确认身份的复合或立体化学，在分配的支持， X-射线晶体结构测定结果和讨论或
实验部分的陈述通常是足够的，但一个球和棒图纸或热椭情节如果需要，可以包括在内。不管结构的讨论，包含数据采集，晶体和晶胞参数，结构的解决方案和完善，以及原子坐标和热参数表的完整细节的晶体信息文件（ CIF ），键长的详细程度的，键角和扭转角应提供的证明资料。反射强度数据（结构系数表）不应该被包括在内。如果有一个以上的晶体结构被报道，到岸价格为每个结构应布置为一个单独的文件。 CIF的应保存以纯文本（ ASCII纯）格式，并应指派识别手稿中使用的结构和数量，其中包括一个“到岸价”（不是“ TXT”）的文件扩展名。之前被提交，CIFS ，应检查并使用在https://www.doczj.com/doc/b210113416.html,/services/cif/checkcif.html免费checkCIF数据验证实用程序，用于其X射线测定包含所有的结构也必须纠正提交
剑桥晶体数据库并分配给在数据库中的化合物的独特号码，必须在该化合物的实验说明被引用。
For combinatorial libraries of more than 20 compounds characterization data must be provided for at least 20 diverse members.
Other material including, for example, molecular modeling coordinates, modeling programs, instrument and circuit diagrams, graphical kinetic data, and non-essential spectroscopic (e.g. IR, NMR, MS and UV/visible) data or other instrumental (e.g. electrochemical or chromatographic) details should be submitted in a separate Supplementary Material File (see 2.5).
对于超过20种化合物组合库特征数据必须提供至少20个不同的成员。
其他材料，包括，例如，分子建模坐标，建模方案，仪器和电路图，图形化的动力学数据，和非必要的光谱（例如，IR，NMR，MS和UV/可见光）数据或其它仪器（例如电化学或色谱）细节应提交在一个单独的补充材料文件（见2.5）。
2.2.15 Acknowledgements (optional)
2.2.16 References (and Notes)
The number of references cited should be limited to 50 for research papers. Long reference lists should be avoided by selecting references carefully and citing reviews, or selecting recent papers which contain many pertinent citations, whenever possible. References may appear in the reference list followed by "and references cited therein" if appropriate. There is no limit to the number of references that may be cited in reviews
and accounts. All references must be cited in the text in numerical order
using superscripts (without brackets). No links between superscripts in the text and actual references in the Reference Section may be used. Authors are asked to assign a separate number to each reference cited (e.g. 1-5), groups of references may not be nested under one number (e.g. 1a-e). All references should be listed in the "References" section at the end of the paper in numerical order with no text between the reference number and the first author's surname (e.g. "3. Jones, A..." not "3. See also Jones, A..."). There must be one blank line between each reference listed. Brief notes may be used to cite manuscripts in preparation, unpublished observations and personal communications, but longer notes should appear in the Supplementary Material section. Reference to experimental procedures or data must not be included in the reference list. The Chem. Abstr. reference should be cited for less accessible literature (e.g., patents). Digital Object Identifier (DOI) numbers should be given for papers cited that have been published online but have yet to receive page numbers. Authors are responsible for obtaining written approval for all personal communications and sending a copy of the manuscript to those cited as authors of personal communications.
引用的参考文献的数量应限制在50篇研究论文。长的参考文献目录应该避免选择
参考仔细援引评论，或选择最近的文章包含了许多中肯的引用，只要有可能。引用可能出现的参考文献列表之后，如果合适的“，并引用的参考文献”中。没有任
何限制，可能会在审查和账目中引用的参考文献数。所有参考文献必须引用在使用上标（不带括号）数字顺序的文本。也可使用在参考部分中的文本和实际的参考标间没有任何联系。作者被要求一个单独的号码分配给每个引用的参考文献（如1-5），不能嵌套在一个数字（例如1A-E ）参照组。所有参考文献应在纸张中的参
考号和第一作者的姓（例如“ 3 。琼斯， A. ..”而不是“ 3之间没有任何文字数字顺序的末尾列出的”参考“部分中。另见琼斯， A. ..“）。必须有品牌BeOne系列中列出的每个基准之间的空行。简要说明可以用于引用手稿，准备，未发表意见和个人通信，但更长的笔记应该出现在补充材料部分。参考实验程序或数据不能被包括在参考文献列表中。该化学。 ABSTR 。引用引用应少接触文学（如专利）。数字对象标识符（ DOI）的数字应该给引论文已在网上公布，但尚未收到页码。作者有责任获得所有个人通讯的书面批准，并发送一份手稿的复印件给那些引为个人通讯作者。
References cited should follow the style below:
PAPERS
1. Bakke, J. M.; Gautun, H. S. H.; Sletvold, I. Arkivoc2001, (x), 26.
2. Herz, W.; Iyer, V. S.; Gopal Nair, M. J. Org. Chem.1975, 40, 3519.
3. Wanner, M. J.; Koomen, G.-J. J. Chem. Soc., Perkin Trans. 12001, 1908.
Although not essential, authors are encouraged to give both the first and last pages of papers (as shown below) but if this is done it must be done for all the references in the manuscript. Wanner, M. J.; Koomen, G.-J. J. Chem. Soc., Perkin Trans. 12001, 1908-1915.
BOOKS
1. Henderson, B.; McIndoe, J. S. In Comprehensive Coordination Chemistry; McCleverty,
J. A.; Meyer, T. J. Eds.; Elsevier: Oxford, 2003; Vol. 1, p 387.
2. Reichardt, C. Solvents and Solvent Effects in Organic Chemistry; VCH: Weinheim, 1990; Vol. 4, pp 298-311.
3. Furniss B. S.; Hannaford A. J.; Smith P. W. G.; Tatchell, A. R. Vogel's Textbook of Practical Organic Chemistry, 5th Edn.; Wiley: New York, 1989; pp 64-67. DISSERTATIONS
1. Lund, K. P. Ph.D. Thesis, Univ. California, San Diego, 199
2.
PATENTS
1. Wright, J. B. U.S. Patent 3 115 496, 1963; Chem. Abstr.1964, 60, P 5512b.
2. Baylis, A. B.; Hillman, M. E. D. Ger. Offen. 2 155 113, 1972; Chem. Abstr.1972, 77, 34174.
3. Buntain, I. G.; Hatton, L. R. Eur. Pat. Appl. 295 117, 1988; Chem. Abstr.1990, 112, P 35845n.
4. Alia, J. M.; Backendorf, C. M. P. PCT Int. Appl. 075 903, 2003; Chem.
Abstr.2003, 139, 240348.
CONFERENCE PROCEEDINGS
1. Scott, L. T.; Cheng, P.-C.; Bratcher, M. S. Eighth International Symposium on Novel Aromatic Compounds, Victoria, British Columbia, Canada, July 19-24, 1992: Abstract No. 64.
2.2.17 Authors’ Biographies (only required for reviews and accounts)
Each author should provide a photograph (portrait style, size 2 x 1.5 inches) and a short professional biography at the end of the manuscript.
2.2.17作者简介（只需要审查和账目）
每位作者应提供的照片（画像风格，尺寸2×1.5英寸）和短传专业在稿件的末尾。
2.3 Tables
Each Table should be provided with a descriptive title, above the table, e.g. "Table 1. Synthesis of S-acylcysteines 7a-e". The title, together with the individual column headings, should make the Table, as far as possible, self-explanatory.
Tables should be numbered consecutively with Arabic numerals and must be created using Word table format. Tables should be created using Microsoft Word. Do NOT use ChemDraw, IsisDraw or Tabs to create tables. Tables created in ChemDraw/ ISIS Draw will be returned to the author for proper formatting.
Structures within Tables must be drawn using ChemDraw or ISISDraw.
They must not be inserted as picture images (e.g., JPG) and manuscripts
that do not comply with this requirement will be returned to the author for proper formatting. Tables must be oriented portrait style on the page and must fit within the margins of a single page. Larger tables will be published as Supplementary Material. Structure numbers should be used in tables rather than chemical structure graphics. Tables should be inserted in the text close to the point where they are discussed. When inserting tables, do not use the "text wrapping"around the table option.
每个表应该具有描述性的标题，上面的表格，例如提供“表1 。合成
S- acylcysteines 7A -E的”。标题，配以单独的列标题，应使表，尽可
能的，不言自明。
表格应连续用阿拉伯数字进行编号，并且必须创建usingWord表格格式。应该使用Microsoft Word中创建的表。请勿使用的ChemDraw ，IsisDraw或制表符来创建表。在的ChemDraw / ISIS抽奖创建的表将被
退回给作者，以正确的格式。
表内的结构必须使用的ChemDraw或ISISDraw绘制。他们不能被插入
的画面图像（如JPG ），并且不符合此要求的稿件将被退回给作者，
以正确的格式。表必须面向在页面上纵向的风格，而且适合在单个页
面的页边距。较大的表将作为补充材料。结构数应在表中，而不是化
学结构的图形被使用。表应插入文字接近的地方，他们正在讨论的点。当插入表格，不要使用“文字环绕”围着桌子选项。
Example:
2.4 Graphics
2.4.1 Schemes, equations, and structure blocks
Scheme: depicts a series of chemical transformations containing chemical structures. Equation: illustrates a simpler transformation with a single reaction arrow.
Structure Block: a collection of one or more numbered structures.
All graphics appear in the text immediately following the paragraph in which they are first mentioned.
2.4.1计划，方程和结构块
计划：描绘了一系列含有化学结构化学转化。
公式：示出了具有单个反应箭头简单变换。
构造块：一个或多个编号的结构的集合。
所有的图形显示在立即在它们第一次提到的段落下面的文字。
For preparation of Schemes, Equations, and Structure Blocks, CS ChemDraw is the recommended drawing program, but ISISDraw may also be used (other programs are not
acceptable). Do not insert the Schemes, Equations, and Structure Blocks as picture images.
对于准备计划，方程和结构块，CS的ChemDraw是推荐的绘图程序，但ISISDraw
也可使用（其他程序都不能接受）。请勿将本计划，方程和结构块作为画面图像。With ChemDraw or ISISDraw the following settings should be used:
Text font: Arial, 10 pt
Fixed length: 14.4 pt (0.508 cm, 0.2 in)
Bold width: 2.0 pt (0.071 cm, 0.0278 in)
Line width: 0.6 pt (0.021 cm, 0.0084 in)
Bond spacing: 18% of width
Hash spacing: 2.5 pt (0.088 cm, 0.0347 in)
文字字体：宋体，10磅
固定长度：14.4磅（0.508厘米，0.2）
大胆宽度：2.0磅（0.071厘米，在0.0278）
线宽：0.6分（0.021厘米，在0.0084）
键间距：宽度18％
哈希间距：2.5磅（0.088厘米，在0.0347）
Owing to the incomplete implementation of the MATH tag in some of the most popular browsers, efficient handling of mathematical equations is not possible. Therefore, authors should create their mathematical equations in a layout program of their choice and then save the equation as an image in jpg format.
Within Schemes, Equations, or Structure Blocks, individual structures may be numbered with boldface Arabic numerals and lower case letters, e.g. 32a, 32b.
Schemes or chemical equations must be cited in the text using Arabic numerals, e.g. Scheme 1, Equation 1 etc.
Captions should be presented separately from the Scheme and Equation.
由于完全执行中的一些最流行的浏览器的数学标记，数学公式的有效处理是不可能的。因此，作者应该在他们所选择的布局程序中创建自己的数学方程式，然后保存该方程为jpg格式的图像。
在计划，方程或结构块，个别结构可能被编号与粗体阿拉伯数字和小写字母，例如：器32a，32b。
计划或化学方程式必须在文本中使用阿拉伯数字，如引方案1中，式（1）等。
标题应分别从计划和公式呈现。
Examples:
Scheme 1. Synthesis of the known azide 6 from bromide 5 and sodium azide.
log k = (-2.62 ± 0.40)σ - (1.69 ± 0.17) (1)
When inserting Schemes, Equations, and Structure Blocks; do not use the float over text option.
2.4.2 Figures
Diagrams, graphs, spectra, photographs, and any other illustrations should all be considered Figures.
Figures should be labeled sequentially with Arabic numerals as they appear, i.e. Figure 1 etc. together with a caption appearing separately below each Figure.
Figures should be included within the body of the manuscript close to the relevant text, but at the end of a paragraph.
Color art 300 dpi
图表，曲线图，光谱，照片，以及任何其他的插图都应该考虑的数字。
数字顺序应该用阿拉伯数字，因为它们出现，即图1等连同标题中出现的每个图下面分别进行标记。
图应包括稿件靠近相关文字的体内，但在段落的末尾。
色彩艺术300 dpi的
Example:
Figure 1. Lowest energy conformations obtained for BP6 superimposed with the structure obtained experimentally by X-ray crystallography (yellow, C – grey, N – blue, O – red, P – violet, H – white.
2.5 Supplementary Materials (optional)
Supporting information such as extended Tables, spectra, etc. may be published as Supplementary Material at the discretion of the author or upon request by a referee or the Scientific Editor. Supplementary Material should have a title page containing the information containing the information below:
Title of the manuscript;
Author's name(s);
Author's address(es);
Table of Contents with the page numbers of all the data;
All pages must be numbered as S1...
Tables, graphics, figures should be numbered as Table S1 or Scheme S1, or Figure S1.
Readers will be able to access supporting information using the link "Supplementary Material" in the journal issue contents page.
支持信息，如扩展表，光谱等可以由裁判或科学编辑出版作为补充材料在作者的自由裁量权或根据请求。补充材料应该有一个包含包含以下信息的信息的标题页：
稿件的标题;
作者姓名（S）;
作者的地址（ES）;
表中所使用到的数据的页码的内容;
所有页面必须被编号为S1...
表格，图形，数字编号应为表S1或计划S1，或图S1。
读者将能够使用在期刊发行内容页面的链接“补充材料”访问支持信息。
2.6 Graphical Abstract
A graphical abstract must be supplied with each manuscript. This graphic, in conjunction with the manuscript title and the author's name(s), should give the reader an impression of the chemistry described in the paper. It is not intended to be a written abstract, should not be detailed, and is not intended to summarize the results.The structure blocks, equations and schemes included in the graphical abstract should be created in Chem Draw or ISIS Draw and formatted according to the instructions under (2.4.1). The Graphical Abstract must be prepared using the template provided.
3. Submission of Manuscript
3.1 Submission procedure
Manuscripts should be submitted via the Arkivoc online submission site https://www.doczj.com/doc/b210113416.html,/arkivoc-journal/online-submission/. In order to submit, the corresponding author should login or register if using it for the first time. After login, click …Submit Manuscript?, read the disclaimer and proceed to Step 1. On the Step 1 form please enter your contact information and add co-authors' names as they appear in the paper masthead. You may add more than one co-author by using the …Add co-author? button. After completing the first step click on …Proceed to step 2?. On the next form you will need to complete the Manuscript Title, select the Manuscript Type and the Issue to which the manuscript belongs. Please type in all the information. Copying and pasting may create invalid characters. To add Greek letters and format text to the title use the appropriated buttons. You must suggest the names of at least 3 referees for review. Step 3 will allow you to upload Manuscript, Graphical Abstract and Supporting Information files. We only accept Microsoft Word (.doc) file format. On Step 4 review your previously inputted information and submit your manuscript.
i. Manuscript
ii. Graphical Abstract
iii. Supplementary Material (optional or upon request by referees or the Scientific Editor).
iv. Suggestions for the names of three referees: the authors are required to provide the name, institution, and e-mail address of each referee.
3.2 Refereeing procedure and editing of the manuscript
All manuscripts approved by the Primary Review Committee will be reviewed by designated Arkivoc referees.
The Scientific Editor will receive reports from the referees. Upon receipt of referees' reports the Scientific Editor will make a decision: accepted, rejected or referred back to authors.
行业消息、通讯、评论的投稿要求 李季 让消息鲜活起来 消息，是最常见的新闻体裁，也是本报刊发量较大、通讯员经常投稿的体裁。写好消息，让编辑从每天几百篇来稿中一眼相中自己的稿子，应避免以下常见误区。 第一，政治意识不强。 具体到烟草行业，国家局要求新闻宣传坚持正确的政治方向，坚持“三贴近”（贴近行业、贴近企业、贴近职工）的原则，弘扬主旋律，紧紧围绕行业中心任务，努力提高新闻宣传报道质量，充分发挥新闻宣传报道工作对行业统一思想、鼓舞士气、推动工作、保持稳定的作用。这不仅是对行业媒体的政治要求，也是烟草行业的新闻工作者应遵守的共同准则。 具体到写稿，讲政治最重要的就是把握一个度的问题。比如，国家局党组一再强调的“大市场、大企业、大品牌”战略，围绕这一课题，有的同志可能就写当地工商企业如何密切合作共育品牌，但是，如果文章中一再强调地域性品牌，就有地方保护的嫌疑了。例如，有稿件中通篇提到的工商共育品牌都是地产烟，这样的稿子就不好发了。再如，有的稿件写企业如何大力推进多元化经营，并将其作为主要成绩，这也不合适。因为行业有“做精做强主业，保持平稳发展”的要求，脱离了主业大谈多元化无疑有违行业发展大方向。 讲政治，也是讲规范。大家写完稿后应多检查几遍，特别是日期、人名、地名、职务、数字等，尽量避免常识性错误。 讲政治，还要把握跟紧形势的问题。我们通常说媒体是喉舌，就是说，作为行业媒体，要起到上传下达的作用：把国家局党组对行业工作的各项指示，采取多种报道手法向全行业传达；同时，又要把各地对国家局工作要求的落实呈现在媒体上，供国家局领导和全行业参考。当然，跟紧形势，最主要的就是紧紧围绕行业工作主线和中心任务，紧跟国家局近期关注的热点问题，做好各自层面的报道。 第二，发掘新闻点发生偏差，缺少全局眼光。 消息内容为自认为本单位某项工作是先进的、具有突破性的，但在全国范围内已经全面推广的或者已经报道过了。这种消息就不适合在面向全国发行的正报刊发。 第三，缺乏实质性的新闻内容，罗列文件语言。 我们收到的消息中经常出现诸如“近日，某某单位进一步加大工作力度，提出‘打牢三个基础’、实现‘五个提高’”之类的导语，可能下面还有“一是进一步加强思想教育……；二是成立领导小组……”实际上这是典型的文件语言，属于千篇一律的模式，它首先就不符
《中国科学技术大学学报》征稿须知（官方认证） 《中国科学技术大学学报》是在郭沫若、华罗庚和严济慈等一大批老一辈科学家直接关怀下于1965年在北京创刊的，先后有30位院士担任编委。由中国科学院主管，中国科学技术大学主办，为综合性自然科学核心学术期刊（月刊，国内外公开发行），主要刊登具有创新性、高水平的学术论文和研究成果以及由科学大家或知名教授撰写的反映学科前沿的综述，并且开辟专家论坛，就一些科学热点研究问题进行有益的讨论。 欢迎国内外学者投稿，中英文稿均可。 1 栏目 本刊设研究论文、研究快报、综述和论坛等栏目。 1.1 研究论文介绍某一课题高水平研究成果。来稿要求内容充实，推论严谨，数据可靠、完整，文字精炼，结论正确。可以发表系列论文。 1.2 研究突破简要、快速报道某一研究工作的创新性、高水平的阶段性成果和主要结论。要求方法从简、数据完整，结论明确，篇幅不超过3000字。发表研究快报后，深入研究的论文仍可在国外学术刊物或本刊上全文发表。 1.3 特约评述综述某一重要研究领域的代表性成果，评论研究现状，提出尚待解决的问题，并指明今后研究方向。一般约请科学大家或知名教授撰写，作者亦可向编辑部自荐。
1.4 专家论坛就科学研究热点问题提出解决问题的新思路，发表不同的见解或进行必要的有益讨论。 2 投稿要求和注意事项 2.1 正文书写顺序标题(一般不超过20个汉字)、作者姓名、作者单位，所在城市及邮政编码、中文摘要、关键词(3～8条)、中图分类号（数学稿还须提供AMS Subject Classification）、与中文相对应的英文标题、作者姓名（汉语拼音，姓前名后，姓全大写，名首字母大写）、作者单位译名、英文摘要、英文关键词、正文、参考文献。若为英文稿，题名不超过100个字符，书写顺序同上。 在文稿首页地脚处注明基金资助项目名称及项目号（将作为论文评审时参考的重要背景资料），并对第一作者（姓名，性别，出生年，学位，职称，目前主要从事的研究方向及E-mail）与通讯作者（姓名，学位（博士以上才注），职称（教授以上才注），E-mail及必要的联系电话）简要介绍。通讯作者是课题负责人或导师，要及时负责对读者的问题给予解答。 2.2 对摘要的要求摘要内容应包括有与论文同等量的主要信息，应说明研究目的、采用的方法、研究成果及结论四个部分。中英文摘要需对应。中文摘要约250个汉字，英文摘要约1500个字符。请参照EI，SCI要求，避免使用“This paper,in this paper（本文）”或“I（我）”等，用词要客观，尽量减少不必要的修饰。 2.3 对量、单位及符号的要求文中物理量、计量单位及符号的使用必须符合国际标准和国家标准（GB310093~GB3102-93）。正确书
《中华护理杂志》 编辑部投稿须知指南 期刊简介：《中华护理杂志》为中华护理学会主办、国内外公开发行的综合性护理学学术期刊，主要报道护理学领域领先的科研成果和临床经验，以及对护理临床有指导作用的护理理论研究。本刊的办刊宗旨是：贯彻党和国家的卫生工作方针政策，贯彻理论与实践普及与提高相结合的方针，反映我国护理临床科研工作的重大进展，促进国内外护理学术交流。 刊名：《中华护理杂志》，英文：《Chinese Journal of Nursing》。主办单位：中华护理学会。编辑单位：《中华护理杂志》编辑委员会；《中华护理杂志》编辑部。地址：北京市朝阳区十里堡甘露西园1号楼314室。邮政编码：100025。电子邮件：zhhlzz@https://www.doczj.com/doc/b210113416.html, 。国际刊号：0254-1769。国内刊号：11-2234/R。期刊种类：月刊。 栏目设置：本刊辟有论著、临床护理研究、护理管理、护理教育、专业化教育与培训、综述、中医护理、基础护理、医院感染控制、手术室护理、探索与争鸣、研究生园地，社区护理、论坛、国外护理评介、经验与革新、编读往来、中外护理动态、护理史话、人文织锦等栏目。 《中华护理杂志》是中国科技论文统计源期刊、中国生物医学核心期刊中国临床医学类核心期刊。至2007年底已连续六届荣获“百种中国杰出学术期刊”称号。《中华护理杂志》系中华临床医学会主办的临床护理专业期刊，中文版每月
30日出版一期。热忱欢迎广大读者踊跃投稿和订阅。 一、投稿要求和注意事项 1、文字要求。来稿应具先进性、科学性和逻辑性，要求资料真实、数据可靠、论点明确、结构严谨、文字通顺。论著、综述类一般不超过5000字，经验交流不超过3000字，简报、病例报告不超过2000字。邮寄稿件请作者以A4纸张打印并核对清楚，尤其标点符号，标点符号占一格，英文应隔行打印。为提高审稿效率，条件允许的作者请优先选择电子邮件的方式投稿。不准一稿多投，文责自负，自留底稿，一律不退。 2、稿件处理。编辑部对来稿及时进行处理，一般在接稿后一周内将“稿件受理通知”通过电子邮件发送给第一作者或通讯作者。若作者投稿15日后仍未接到“稿件受理通知”请即来E-mail咨询。编辑部对来稿有删修权，不同意删修者必须来E-mail声明。实验研究、新技术研究类优越稿件酌致稿酬。本刊大16开，月刊，稿件容量大，发表周期短，一般不超过30个工作日。凡在接到本刊受理回执后1个月内未接到稿件终审通知者，系文章仍在排队审理中。凡投寄本刊的稿件，2个月内（以稿件受理回执日期计算）给予回复审稿意见。未经录用稿件，允许作者提出不同意见。本刊不退原稿，请作者自留底稿。作者如欲投他刊，请先与本刊联系，切勿一稿两投，耗费专家评审精力。 3、投稿方式。电子邮件投稿（即网络投稿）请用Word格式的附件来邮；邮寄来稿请尽量用小四号字打印在A4纸上，凡字迹潦草、涂改不清的稿件，恕
《草地学报》投稿须知 《草地学报》是中国科技核心期刊，由中国科协主管，中国草学会主办，国内外公开发行。本刊以登载草地科学及相关领域高质量研究论文为主，兼发少量专稿、综述、研究简报和博士论文摘要。欢迎国内外有关人士不吝赐稿。 本刊同时接受中、英文稿件。来稿应论点明确，材料翔实，数据可靠，文字精炼。一般专稿和综述不超过6个印刷页，研究论文限4页(6000左右)，研究简报和博士论文摘要2页。超出部分将酌加版面费。 1.稿件处理8项原则 1.1 来稿如不符上述规范，将退请作者修改，达到要求后再行受理。 1.2 来稿最好电子邮件统一发送到邮箱：cdxbqk@https://www.doczj.com/doc/b210113416.html, （Word文档），纸质稿请用A4纸打印，一式两份。 1.3 来稿文责自负，请勿一稿两投；内容应无泄密之处，署名无误。 1.4 编辑部受理稿件2个月内将结果通知作者。 1.5 返作者修改稿无故逾3个月未修回者，视为自行退稿。 1.6 编辑部对采用的稿件，将在文字上作必要修改。 1.7 稿件一般按受理先后次序发表，重大科研成果可优先发表，出版前需交纳发表费。 1.8 本刊已被多家数据库和文摘杂志列为固定刊源，或摘要转载，或全文上网、进入光盘版杂志，作者若无特别声明，即视为无异议，稿件采用后，作者著作权使用费与本刊稿酬一并付给，并赠送样刊。 2.文章要素及规范 中英文题名、作者姓名、作者单位、城市名、邮政编码、摘要、关键词；正文（包括前言、材料与方法、结果与分析、
讨论、结论）；参考文献。在首页地脚处注明：①基金项目（资助项目名称、编号）；②作者简介（第一作者和通讯作者姓名，性别，民族，出生年，学位，职称，研究方向）及联系方式（电话、E-mail）。 题名(中、英文对应) 务求简明确切，一般不要超过20个字。摘要200～300字为宜，概述研究目的、材料、方法、结果和结论，突出创新性成果；英文在此基础上可适当扩大信息量（如研究背景等）。 关键词（中、英文对应）3～8个；尽可能列出文章的中图分类号。 正文章、条序码用阿拉伯数字表示，各级号码间加圆点，一般不超过4级；计量单位须符合新版国标(GB3100 3102-93)规定；外文符号的文种、正斜体、大小写和行文中的上、下角标必须规范；生物学名称第一次出现时应注明拉丁学名，种属名为斜体。 图、表须具自明性，插入文中相应部位。图题和表题及其中的标注均需中、英文（或拉丁文）对照，并与正文表达一致；非公知公用的缩写符号应给出中、英文注释。表须用三线表。 参考文献只列出与本文有关的近期主要文献，未公开发表的不能引用。文献采用顺序编码制著录,文中按其出现先后顺序用阿拉伯数字连续排序，视具体情况将序号作为上角标，或作为语句的组成部分。如：李刚［1～3］做了大量……；……按文献［８］提供的……。文后则按其在文中的序号顺序排列。著录示例： a 专著：［序号］著者.书名.版本（第一版不著录）［M］.出版地：出版者，出版年.页次 ［1］谭炳煜.怎样撰写科学论文［M］.沈阳:辽宁人民出版社, 1982.59 ［2］Eissen H N. Immunology: an introduc tion to molecular
中国土地科学杂志投稿须知 刊名：中国土地科学 China Land Science 主办：中国土地学会;中国土地勘测规划院 周期：月刊 出版地：北京市 语种：中文; 开本：大16开 ISSN： 1001-8158 CN： 11-2640/F 历史沿革： 现用刊名：中国土地科学 创刊时间：1987 该刊被以下数据库收录： CBST 科学技术文献速报(日)(2009) 中国科学引文数据库(CSCD—2008) 核心期刊： 中文核心期刊(2008) 中文核心期刊(2004) 根据《中国学术期刊（光盘版）》检索与评价数据规范的要求，来稿需符合以下规定： 1、在篇首标明作者姓名、论文署名的单位（全称）、及单位所在省市、邮编（附英文）。 2、稿件须有：摘要220字左右（归纳文章的主要内容，切忌使用“本文”如何、“文章”如何这类评价性、解释性、介绍性的词语）、关键词（3—6个）（附英文摘要、关键词）；作者简介：姓名、出生年、性别、民族、籍贯或出生地、工作单位、职务或职称、学位、研究方向。 3、作者须提供：详细的通信地址、邮政编码、联系电话、电子信箱。 4、来稿中的注释与参考文献分别排列。注释是对文章篇名、作者及正文中某一特定内容的进一步解释或补充说明，序号用数字加圆圈标注。参考文献是作者写作论文时所参考的图书报刊等资料的引文。参考文献条目的编排格式如下：[序号]主要责任者.文献题名.刊名或出版地,起止页码.{刘国东.农村劳动力有序转移的经济意义[J].商业经济,2001,(9):10-18)} 5、所有来稿，字数以4000—8000字为宜，来稿以word 格式发送电子邮件。 投稿邮箱：boyalunwen@https://www.doczj.com/doc/b210113416.html,（请注明所投期刊名）扣扣：1754477038 学术期刊论文撰写格式 1.文章标题：一般不超过20个汉字，必要时加副标题，并译成英文。 2.作者姓名、工作单位：题目下面均应写作者姓名，姓名下面写单位名称（一、二级单位）、所在城市（不是省会的城市前必须加省名）、邮编，不同单位的多位作者应以序号分别
《土壤学报》投稿须知（官方认证） 《土壤学报》（ACTA PEDOLOGICA SINICA；国内统一刊号：CN 32-1119/P，国际标准刊号：ISSN 0564-3929）是由中国科学院主管、中国土壤学会主办、中国科学院南京土壤研究所承办、科学出版社出版的中文（含英文摘要、图、表和关键词）核心科技学术期刊。 《土壤学报》的前身是《中国土壤学会会志》（Bulletin of the Soil Science Society of China），于1948年12月创刊。1952年更名为《土壤学报》。1955―1956年定期出版，为半年刊，科学出版社出版。1957年起由半年刊改为季刊，全国各地邮局发行。1966年下半年由于科研工作停顿停刊。1978年8月经中国科学院批准正式复刊。该刊历任主编：1948年主编宋达泉；1950―1954年主编马溶之；1955―1983年主编熊毅；1984―1996年主编鲁如坤；1996―2003年主编季国亮；2004―2012年主编蔡祖聪；2012年起主编史学正。 《土壤学报》反映土壤学各分支学科有创新或有新意的、具有较高学术价值的研究成果，主要刊登土壤科学及相关领域，如植物营养科学、肥料科学、环境科学、国土资源等领域中具有创造性的研究论文、研究简报、前沿问题评述与进展、问题讨论、书评。主要读者对象为土壤学及相关学科的科技人员、高等院校师生和管理人员。 该刊是我国土壤学科领域高水平学术刊物，为中国期刊方阵期刊、中国科技核心期刊、中文核心期刊、全国百种杰出学术期刊。该刊在国内享有较高声誉，为《中国科技论文与引文数据库（CSTPCD）》、《中国科学引文数据库(CSCD)》、《中国科技期刊引证报告（CJCR）》、《中国期刊全文数据库（CJFD）》、《中国学术期刊文摘（CSA）》、《中国学术期刊综合评价数据库（CAJCED）》、《中国核心期刊（遴选）数据库》、《中国科技期刊精品数据库》等的来源期刊和《中国知网》、《中国学术期刊（光盘版）（CAJ-CD）》、《万方数据系统科技期刊群》、《中文科技期刊数据库（VIP）》的收录期刊。同时该刊在国际上也有一定影响，被Chemical Abstract (CA)、CAB Abstracts系列、FAO Agris AGRINDEX 等国际重要数据库和检索系统收录。 该刊办刊宗旨：坚持四项基本原则，理论联系实际，贯彻“双百”方针，为发展国民经济服务，为科教兴国服务，为农业现代化服务，为土壤学科发展服务。《土壤学报》创刊以来，始终坚持贯彻正确的办刊宗旨，刊登论文的学术水平和编辑出版质量不断提高。该刊反映了土壤科学研究的发展轨迹和理论水平的提高，并推动了科研出成果、出人才，同时该刊也是中国土壤学界与国际土壤学界进行学术交流的重要窗口。该刊在国际上已与英、美、日、德等国家的多家机构和个人建立了订阅与交换联系，成为国际同行所重视的学术刊物。 该刊为双月刊，大16开，192页，国内外公开发行。国内邮发代号：2-560，国外发行代号：BM45；每期定价60.00元，全年定价360.00元。全国各地邮局均可订阅。
附件1 烟草科技期刊论文撰写 基本要求(YC/T 467—2013) 本标准按照GB/T 1.1—2009给出的规则起草。本标准由全国烟草标准化技术委员会企业分技术委员会（SAC/TC 144/SC 4）归口。本标准起草单位：中国烟草学会、中国烟草总公司郑州烟草研究院、中国农业科学院烟草研究所。 为增强烟草行业科技期刊论文的严谨性、规范性和科学性，提高论文的可读性和编辑出版工作效率，促进学术交流和科技成果的转化应用，制订本标准。制订本标准的原则是在符合国家标准的总体框架下，对一些未被国家标准覆盖到或规定不够详细的事项提出基本要求。 范围 本标准规定了烟草行业科技期刊论文撰写的基本要求。 本标准适用于烟草行业试验研究类论文、应用技术类论文和综述类论文的撰写，其他类型论文的撰写可参考使用。 规范性引用文件 下列文件对于本文件的应用是必不可少的。凡是注日期的引用文件，仅所注日期的版本适用于本文件。凡是不注日期的引用文件，其最新版本（包括所有的修改单）适用于本文件。 GB 3101 有关量、单位和符号的一般原则 GB/T 3358.1 统计学词汇及符号第1部分：一般统计术语与用于概率的术语 GB/T 6447—1986 文摘编写规则 GB/T 7713—1987 科学技术报告、学位论文和学术论文的编写格式 GB/T 7714 文后参考文献著录规则 GB/T 15835 出版物上数字用法 GB/T 16159 汉语拼音正词法基本规则 术语和定义 下列术语和定义适用于本文件。 学术论文 academic paper
是某一学术课题在实验性、理论性或观测性上具有新的科学研究成果或创新见解和知识的科学记录；或是某种已知原理应用于实际中取得新进展的科学总结，用以提供学术会议上宣读、交流或讨论；或在学术刊物上发表；或作其他用途的书面文件。 注：改写GB/T 7713—1987，定义2.3。 试验研究类论文 paper on experimental study 针对科技领域的一个专题，分析所进行的试验与研究及得到的观察现象、实验数据或效果比较等重要的原始资料，并得出结论的书面文件。 应用技术类论文 paper on applied technology 应用国内外已有的理论来解决设计、技术、工艺、设备、材料等具体技术问题而取得的研究成果的书面文件。主要包括系统开发类论文和技术改进类论文等形式。 3.3.1 系统开发类论文 paper on system development 介绍根据需求开发的应用系统的结构、功能等情况，突出系统的应用价值和技术先进性的书面文件。 3.3.2 技术改进类论文 paper on technological upgrading 为了实现某些新功能或改善原有功能对原来的对象进行升级改进，介绍其改进方案及实施步骤，分析、解决存在问题的书面文件。 综述类论文 review 利用已发表的文献资料作为原始素材，对某学科的近期研究情况进行综合论述，并提出该学科存在问题和未来发展趋势的书面文件。 题名 title 以最恰当、最简明的词语反映论文中最重要的特定内容的逻辑组合。 摘要 abstract 以提供内容梗概为目的，不加评论和补充解释，简明、确切地记述文献重要内容的短文。 注：改写GB/T 6447—1986，定义2.1。
题目 作者1①②*, 作者2②, 作者3③ ①单位1, 所在地邮编; ②单位2, 所在地邮编 * E-mail: 收稿日期: 2009-00-00; 接受日期: 2010-00-00 ××××基金资助项目(批准号: ××××) 摘要单击此处键入中文摘要. 应反映出论文的主要观点, 概括其结果或结论. 摘要的撰写要精心构思, 随意从文章中摘出几句或只是重复一遍结论的做法是不可取的. 摘要中不能出现文献序号. 关键词关键词1, 关键词2, 关键词3… PACS:21.10.Jx, 46.90.+s, 46.15.-x 单击此处键入前言内容. 1标题1 1.1子标题1 正文中文使用宋体10号字体, 英文使用Times New Roman 10号字体. 2标题2 公式居行中，按顺序编码排列。 (). d g Y (1) 3标题3 3.1 子标题1 正文中文使用宋体10号字体, 英文使用Times New Roman 10号字体. 3.2 子标题2 4 标题4 图1如图所示。
图1 这里添写图题5标题5 (1) 结论; (2) 结论; (3) 结论; (4) 结论. 参考文献 1Wang Q H, Lindon O, Hardle W. Semiparamet-ric regression analysis with missing response at random. J Am Stat Assoc, 2004, 99: 334―345 2Rordam M, Larsen F, Lausten N. An introduction to K-theory for C*-algebras. Cambridge: Cam-bridge University Press, 2000. 30―35 3Qin H R. The subgroups of a finite order in K(Q). In: Bass H, Kuku A O, Pedrini C, eds. Algebraic K-theory and Its Application. Singapore: World Scientific, 1999. 600―607 4Minor H E. Spillways for high velocities. In: Zu-rich V E, Minor H E, Hager W H, eds. Proceed-ings of International Workshop on Hydraulics of Stepped Spillways, Rotterdam, the Netherlands, 2000. 3―10 5Liu G X. Classification of finite dimensional basic Hopf algebras and related topics. Disertation for the Doctoral Degree. Hangzhou: Hangzhou University, 2005. 24―28 6Phillips N A. The Nested Grid Model. NOAA Tech-nical Report NWS22. 1979 7苏晓龙, 贾晓军, 谢常德, 等. 用正交压缩态光场产生连续变量类GHZ和类Cluster四组分纠缠态. 中国科学G辑: 物理学力学天文学, 2007, 37(6): 689—699 8Zhang W P. Experiment Apparatus of Diffraction Imaging. China Patent, 02290557.X, 2003-12-03 9Wang D L, Zhu J, Li Z K, et al. User Manual for QTKMapper Version 1.6, 1999 10Hemodynamics III: The ups and downs of hemodynamics. Version 2.2. Orlando (FL): Computerized Educational Systems. 1993 11Christine M. Plant physiology: Plant biology in the Genome Era [OL]. Science, 2003, 281: 331―332 [2003-09-23]. anatmorp.htm 12 傅景礼, 陈立群, 陈本永. 非规范格子离散机电耦合动力系统的Noether理论. 中国科学: 物理学力学天文学, 2010, 40(2): 133―145 13 He C J, Zhou H B, Hang Y H. A numerical study on Rayleigh-Taylor instability of aluminum plates driven by detonation. Sci China Phys Mech Astron, 2010, 53(2): 195―198 Title Author 11,2*, Author 22 & Author 33 1 Address 1; 2 Address 2;… A precise dynamical model to describe the relative motion of a lunar probe in a rotating coordinate system is presented. Real celestial mechanics background of the sun, the earth and the moon is considered. An accurate and simple formula of the absolute angular velocity of the rotating coordinate system Including solar gravitational perturbation is derived. The model would be the one for elliptical restricted three-body problem if the solar gravitation was neglected, and the one for circular restricted three-body problem if the lunar orbit eccentricity was zero. An iterative method to calculate accurate collinear and triangular Lagrange points, which are relevant to the Julian date and time period concerned, was established. The model can be used to design transfer orbit to the moon passing through the Lagrange points. lunar probe, relative orbital dynamics, Lagrange point, four-body problem, solar gravitational perurbation PACS:05.45.-a, 45.50.Jf, 45.50.Pk, 95.55.Pe, 96.12.De 345 / 3
《 》杂志投稿须知 《药物评价研究》杂志是中国科技核心期刊（中国科技论文统计源期刊）、RCCSE 中国权威学术期刊，由中国药学会和天津药物研究院共同主办，2017年起变更为月刊，国内外公开发行。本刊的办刊宗旨为：报道药物评价工作实践，推动药物评价方法研究，开展药物评价标准或技术探讨，促进药物评价与研究水平的提高，为广大药物研究人员提供交流平台。针对药物及其制剂的评价规范以及药学评价、安全性评价、药效学评价、药物代谢动力学评价、临床评价、上市药物评价等评价研究的内容，设置论坛、综述、方法学研究、试验研究（论著）、审评规范、国外信息、专题等栏目。《药物评价研究》杂志目前已被CNKI 中国期刊全文数据库、万方数据库、波兰《哥白尼索引》（Index of Copernicus ，IC ）、美国《乌利希期刊指南》（Ulrich's Periodicals Directory ，Ulrich PD ）、美国《化学文摘（网络版）》（Chemical Abstracts ，CA ）、英国国际农业与生物科学研究中心（CABI ）等收录，并由中国知网独家全文发布和优先出版。 1 投稿要求 1.1 介绍信 投稿须附单位主管学术部门的介绍信（综述文章除外），注明内容真实、无一稿两投、署名无争议、无泄密内容。已在非公开发行的刊物上发表或学术会议交流过的必须注明。 1.2 投稿方式 本刊采用在线投稿、审稿、查询系统，作者可登陆www.中草药杂志社.中国或https://www.doczj.com/doc/b210113416.html, 投递、查询稿件，不接受纸质投稿。 1.3 医学伦理问题及知情同意 若论文的主题是以人为研究对象，作者应提供单位性的、地区性的或国家性的伦理委员会的批准文件及受试对象或者其亲属的知情同意书。 2 文稿的撰写要求 2.1 文题 每篇来稿均要有中英文题名。中文题名一般不超过20个汉字，应以简明、具体、确切的词语，概括文章的要旨，符合编制题录、索引和检索的有关原则，并有助于选择关键词和分类号。题名中应避免使用非公知公用的缩写词、字符、代号以及结构式或公式。英文题名首字母大写，其他均小写，英文题名中不用冠词，并应与中文题名含义相一致。 2.2 作者及工作单位 作者姓名在文题下按序排列，应限于参加研究工作并能解答该文有关问题及对文稿内容负责者。若第一作者或第一单位有变动，应有单位证明信。对论文有贡献的其他人员如 协助工作或提供资料、材料者可放在致谢项。姓氏的汉语拼音字母全部大写，复姓应连写；名的首字母大写，双名中间加连字符。工作单位名称列于署名之后，用全称，不用简称或缩写，工作单位后写出所在省、市及邮政编码，并附单位英文名称，应与中文单位名称对应。通信作者用“﹡”标出，并在论文首页脚注通信作者姓名、E-mail 地址等联系方式。英文摘要中的作者工作单位还应在城市名称及邮政编码之后加列国名，其间以“，”分隔。 2.3 地脚线 ①收稿日期：由本部填写收稿的具体日期。②基金项目：应注明国家有关部门的正式基金名称的全称及编号。③作者简介：第一作者姓名（出生年—）、性别（民族，汉族可省略）、籍贯、职称、学位及研究方向，并提供详尽的联系方式（电话、传真、E-mail 等）。④通信作者 姓名及联系方式。 2.4 摘要和关键词 文稿需附加中、英文摘要和关键词。中文摘要一般不超过400字，关键词5～8个，中、英文需对应。关键词尽量选用《汉语主题词表》和《中医中药主题词表》中的规范词，主要的自由词和未被词表收录的新学科、新技术中的重要术语也可作为关键词标出。多个关键词之间用“；”分隔。研究性论文的中、英文摘要均采用四要素结构式书写，即目的（Objective ）、方法（Methods ）、结果（Results ）和结论（Conclusion ）。综述性论文需写出指示性摘要，中文200字左右。英文文题、关键词及作者名称和单位须与中文对应。 2.5 正文 一般应包括以下几个部分：①引言；②材料和方法；③结果；④讨论；⑤参考文献。正文应层次分明，在层次标码后，应拟定标题。尽量减少层次，不得多于3层，采用1，1.1，1.1.1方式。层次的数字序号顶格写，序号后要空一个汉字。 2.5.1 引言 一般不超过250字，概述本研究的理论依据、思路、实验基础及国内外现状，并应明确提出论文研究的目的。 2.5.2 材料和方法 清楚地描述观察或实验对象的选择情况，详细实验方法、仪器（注明制造厂商）及步骤，以便他人重复验证。列出建立方法的文献，其中包括统计学方法的文献。对已发表但尚未为人们所熟悉的方法，要提供简要的描述和文献；对新的或有实质性改进的方法要详细介绍并对其限度加以评价。准确说明药物和化学品的使用方法，包括商品名称、剂量以及给药途径。 病理号、药品批号、仪器型号、所用动物的清洁度、种系等均应列出。药名符合《中国药品通用名称》及《国际非
Insect Science征稿简则 Insect Science是一本国际性昆虫学期刊，主要刊登昆虫分子生物学、生理学、生化与毒理学、生态学与害虫综合治理、行为与社会生物学和系统与进化学等昆虫学领域有创新发现的研究论文、综述、评论性文章和简报等。研究论文（Original Article）报导有重要创新性的基础研究结果；综述或评论探讨期刊相关领域的最新研究进展，综述一般由主编或编委事先约稿；简报报导对当今昆虫学研究有重要影响的最新发现。 Insect Science与Wiley-Blackwell合作出版，读者可以在Wiley-Interscience网上检索本刊从创刊（1994年）至今的所有文章。 稿件格式 稿件全文应使用11磅Times New Roman字体，两倍行距，编号所有页面，从标题页面开始，然后依次为摘要，前言，材料和方法，结果，讨论，致谢，参考文献，图注，图片/表格。 标题页（Title page）：包括完整的标题（Title），页眉标题（Running title），通讯作者（Correspondence）的单位，通信地址，电话，传真，E-mail等完整信息（请不要用脚注）。标题应使用对全文概括总结性的语句，应具有一定的启发性和可读性，不超过150个字符（包括空格）；页眉标题以更加精练的语言概括全文的主旨，不超过50个字符（包括空格）。 摘要（Abstract）：扼要介绍研究目的、结果、结论。内容完整，不超过300字。最后须给出不超过6个关键词，按字母顺序排列。 前言（Introduction）：简要介绍研究背景，尽可能简洁明了。 材料方法（Materials and Methods）：详细介绍实验中所使用的材料产品名称，生产商名称，以及产地；对于新的实验方法，必须做详细描述，以便他人参考。对于已经成熟或引用他人的实验方法，可简单描述，但必须提供文献。
INSTRUCTIONS FOR AUTHORS SHOCK\V Injury,Inflammation,and Sepsis:Labora-tory and Clinical Approaches Online Submission and Review System Scope The mission of SHOCK\is to foster and promote multidisciplinary studies,both experimental and clinical in nature,that critically examine the etiology,mechanisms,and novel therapeutics of shock-related patho-physiological conditions.The journal will consider papers in the areas of basic and clinical studies of shock,trauma,sepsis,inflammation,isch-emia,and related pathobiological states,with particular emphasis on the biologic mechanisms that determine the response to such injury. Ethical/Legal Considerations A submitted manuscript must be an original contribution not previously published(except as an abstract or a preliminary report),must not be under consideration for publication elsewhere,and,if accepted,must not be published elsewhere in similar form,in any language,without the consent of Lippincott Williams&Wilkins.Each person listed as an author is expected to have participated in the study to a significant extent. Although the editors and referees make every effort to ensure the validity of published manuscripts,the final responsibility rests with the authors,not with the Journal,its editors,or the publisher. Patient Anonymity and Informed Consent V It is the author’s respon-sibility to ensure that a patient’s anonymity be carefully protected and to verify that any experimental investigation with human subjects reported in the manuscript was performed with informed consent and following all the guidelines for experimental investigation with human subjects required by the institution(s)with which all the authors are affiliated. Authors should mask patients’eyes and remove patients’names from figures unless they obtain written consent from the patients and submit written consent with the manuscript. Conflicts of Interest V Authors must state all possible conflicts of interest in the manuscript,including financial,consultant,institutional, and other relationships that might lead to bias or a conflict of interest.If there is no conflict of interest,this should also be explicitly stated as none declared.All sources of funding should be acknowledged in the manuscript.All relevant conflicts of interest and sources of funding should be included on the title page of the manuscript with the heading‘‘Conflicts of Interest and Source of Funding.’’ For example: Conflicts of Interest and Source of Funding:‘‘Author A’’has received honoraria from‘‘Company1.’’‘‘Author B’’is currently receiving a grant (no.12345)from‘‘Organization Y’’and is on the speaker’s bureau for ‘‘Organization X’’V the CME organizers for Company1.For the remaining authors,none were declared. Copyright V In addition,each author must complete and submit the journal’s Copyright Transfer Agreement,which includes a section on the disclosure of potential conflicts of interest based on the recommendations of the International Committee of Medical Journal Editors,‘‘Uniform Require-ments for Manuscripts Submitted to Biomedical Journals’’(https://www.doczj.com/doc/b210113416.html,/ update.html).The form is available on the manuscript submission page,https:// https://www.doczj.com/doc/b210113416.html,/shock/,and can be completed and submitted electronically.Please note that authors may sign the Copyright Transfer Agreement form electronically.For additional information about electroni-cally signing this form,go to https://www.doczj.com/doc/b210113416.html,/ZUA T/A106. Compliance With NIH and Other Research Funding Agency Accessibility Requirements V A number of research funding agencies now require or request authors to submit the postprint(the article after peer review and acceptance but not the final published article)to a repository that is acces-sible online by all without charge.As a service to our authors,LWW will identify to the National Library of Medicine(NLM)articles that require deposit and will transmit the postprint of an article based on research funded in whole or in part by the National Institutes of Health,Wellcome Trust, Howard Hughes Medical Institute,or other funding agencies to PubMed Central.The revised Copyright Transfer Agreement provides the mechanism. Permissions V Authors must submit written permission from the copy-right owner(usually the publisher)to use direct quotations,tables,or illustrations that have appeared in copyrighted form elsewhere,along with complete details about the source.Any permission fees that might be required by the copyright owner are the responsibility of the authors requesting use of the borrowed material,not the responsibility of Lippincott Williams&Wilkins.Publication Policy SHOCK\publishes regular Research Articles,Rapid Communications, Review Articles,and Letters to the Editor.Please note that SHOCK\does not publish Case Reports.Rapid Communications should be brief reports of especially important and timely findings in the field.Published length should be three to four pages,including figures and references.Reviews will be by invitation of the editor,but recommendations for topics and authors are welcomed.The editor also invites letters expressing comments on dissenting opinions concerning papers recently published in SHOCK\. Letters must not exceed500words and should be submitted double-spaced with any references prepared as for regular research reports.Publication of submitted letters will be at the discretion of the editor.Each author should include his/her complete address,along with telephone,fax,and e-mail.All submitted manuscripts will be critically refereed by at least two members of the editorial board or expert consultants. Preparation of Manuscript Manuscripts that do not adhere to the following instructions will be returned to the corresponding author for technical revision before undergoing peer review. Online Manuscript Submission V Authors are requested to submit their manuscripts online at https://www.doczj.com/doc/b210113416.html,/shock. First-Time Users V Please click the Register button from the main menu and enter the requested information.On successful registration, you will be sent an e-mail indicating your user name and password. Print a copy of this information for future reference.Note:If you have received an e-mail from us with an assigned user ID and password,or if you are a repeat user,do not register again,just log in.Once you have an assigned ID and password,reregistration is unnecessary,even if your status changes(i.e.,author,reviewer,or editor). Authors V Please click the log-in button from the menu at the top of the page and log in to the system as an Author.Submit your manuscript according to the author instructions to the editor:Dr.Irshad H.Chaudry, University of Alabama at Birmingham,Shock Editorial Office,1670 University Boulevard,V olker Hall,Room G094,Birmingham,AL35294-0119).You will be able to track the progress of your manuscript through the system.If you experience any problems,please contact the SHOCK\ Cover Letter V A cover letter should accompany all manuscripts submitted to SHOCK\,indicating that the manuscript has been submitted solely to this journal and has not previously been published in any form in another publication of any type,with the exception of preliminary reports in abstract form.In situations where the review of the submitted manu-script depends highly upon another manuscript submitted for publication but not yet published,a copy of that manuscript should be included with the submission. Manuscripts must be typewritten and double-spaced.Number all pages in sequence beginning with the title page.The sections should be arranged in the following order: Title Page V Include on the title page(a)complete manuscript title; (b)authors’full names and affiliations;(c)corresponding author’s name and address,degree(s),fax number,telephone number,and e-mail address; (d)address for reprints if different from that of corresponding author; (e)all sources of support,including pharmaceutical and industry support,or a statement of no relevant conflicts of interest;and(f)a running head of not more than45characters. The title page must also include disclosure of funding received for this work from any of the following organizations:National Institutes of Health, Wellcome Trust,Howard Hughes Medical Institute,and other(s). Abstract V Submit five to eight key words appropriate for indexing purposes.Do not repeat words or terms used in the title. Keywords V An informative abstract of approximately250words should state concisely the purpose and pertinent methods of the study,as well as the findings and specific conclusions.This abstract should be suitable,without rewording,for use by abstracting journals and indexing services. Text V The text of the manuscript should begin on a new page and be arranged as follows:Introduction,Materials and Methods,Results,and Discussion.The use of subheadings and paragraph titles within these headings is encouraged for sake of clarity.For standard abbreviations, authors should follow the guidelines in the Council of Biology Editors Style Manual,Fifth Edition.All other abbreviations should be defined when first used and listed in a footnote.Authors are encouraged to use 0019(e-mail:Shock@https://www.doczj.com/doc/b210113416.html,;telephone:205-975-0118;fax205-975-Editorial Office(e-mail:Shock@https://www.doczj.com/doc/b210113416.html,).